Immunologix's Grant

Immunologix raised a round of funding on November 17, 2010. Investors include Qualifying Therapeutic Discovery Project.

Immunologix is a human antibody development company founded on a proprietary technology that transforms naive B-cells into fully human monoclonal antibodies targeting any antigen. In October 2011, Im…

Articles about Immunologix's Grant: